Your browser is no longer supported. Please, upgrade your browser.
CLPT ClearPoint Neuro, Inc. daily Stock Chart
ClearPoint Neuro, Inc.
Index- P/E- EPS (ttm)-0.43 Insider Own3.50% Shs Outstand15.50M Perf Week44.33%
Market Cap105.80M Forward P/E- EPS next Y-0.51 Insider Trans0.00% Shs Float10.88M Perf Month30.73%
Income-6.50M PEG- EPS next Q-0.14 Inst Own7.30% Short Float0.63% Perf Quarter55.87%
Sales11.70M P/S9.04 EPS this Y25.30% Inst Trans- Short Ratio0.76 Perf Half Y111.98%
Book/sh0.09 P/B85.56 EPS next Y0.00% ROA-36.10% Target Price10.50 Perf Year86.44%
Cash/sh1.16 P/C6.61 EPS next 5Y30.00% ROE-176.50% 52W Range2.86 - 8.91 Perf YTD60.42%
Dividend- P/FCF- EPS past 5Y32.70% ROI-68.60% 52W High-13.69% Beta0.93
Dividend %- Quick Ratio4.60 Sales past 5Y25.50% Gross Margin70.40% 52W Low168.87% ATR0.60
Employees33 Current Ratio5.60 Sales Q/Q-51.00% Oper. Margin-43.00% RSI (14)71.95 Volatility14.89% 8.73%
OptionableNo Debt/Eq13.62 EPS Q/Q48.70% Profit Margin-55.30% Rel Volume2.13 Prev Close7.70
ShortableYes LT Debt/Eq13.38 EarningsAug 12 AMC Payout- Avg Volume90.76K Price7.69
Recom2.00 SMA2032.29% SMA5054.29% SMA20073.17% Volume173,744 Change-0.13%
Jul-17-20Initiated B. Riley FBR Buy $8
Sep-14-20 04:15PM  
Aug-12-20 04:05PM  
Aug-06-20 08:00AM  
Jul-17-20 09:25AM  
May-12-20 04:05PM  
May-07-20 04:05PM  
Apr-17-20 08:10AM  
Apr-16-20 08:00AM  
Feb-14-20 08:55AM  
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system, a neuro-navigation system designed for insertion of catheters, electrodes, and laser fibers to treat various neurological diseases and conditions, as well as for performing biopsies. In addition, the company's product pipeline includes ClearTrace system, a product candidate designed to allow catheter-based minimally invasive procedures in the heart to be performed in an MRI suite. The company has a license agreements with The Johns Hopkins University; development agreement with Mayo Clinic to design and develop MRI-guided therapies for stroke; and a collaborative license and co-development agreement with Clinical Laserthermia Systems AB. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was founded in 1998 and is headquartered in Irvine, California.